Acorda Therapeutics, Inc.
ACOR
NASDAQ Global Select0.66
USD
-0.21
- -
Total Valuation
Acorda Therapeutics, Inc. carries a market capitalization of 821,028.00, placing it among publicly traded companies globally.
| Market Cap | 821,028.00 |
| Enterprise Value | N/A |
Stock Price Statistics
Acorda Therapeutics, Inc.'s stock has declined approximately -96.06548% over the past 52 weeks. The 50-day moving average sits at 12.10, while the 200-day moving average is 13.17.
| Beta (5Y) | N/A |
| 52-Week Price Change | -96.06548% |
| 50-Day Moving Average | 12.10 |
| 200-Day Moving Average | 13.17 |
| Average Volume (20 Days) | N/A |
Stock Splits
Acorda Therapeutics, Inc.'s most recent stock split took place on June 5, 2023 with a 20:1 split ratio.
| Last Split Date | 6/5/2023 |
| Split Ratio | 20:1 |